Trial Profile
Verification of the effect of lubiprostone on intestinal permeability in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2018
Price :
$35
*
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation; Irritable bowel syndrome
- Focus Pharmacodynamics
- 01 Nov 2018 Status changed from active, no longer recruiting to completed.
- 06 May 2015 New trial record